Literature DB >> 30572742

Portal hypertension predicts short-term and long-term outcomes after hepatectomy in hepatocellular carcinoma patients.

Yan-Wen Zheng1, Kun-Peng Wang1, Jiang-Jiao Zhou1, Ze-Qun Zhang1, Li Xiong1, Yu Wen1, Heng Zou1.   

Abstract

BACKGROUND AND AIMS: The impact of portal hypertension (PH) on postoperative short-term outcomes and long-term survival in hepatocellular carcinoma (HCC) patients has lately been discussed controversially. This study aimed to explore the influence of PH on postoperative outcomes in HCC patients undergoing surgical resection.
METHODS: Patients undergoing hepatectomy for HCC from 2010 to 2014 were enrolled. The impact of PH on postoperative complications, posthepatectomy liver failure (PHLF) and overall survival (OS) was evaluated.
RESULTS: A total of 355 HCC patients were enrolled; 129 (36.3%) experienced postoperative complications and 21 (5.9%) developed PHLF. PH was identified as an independent predictor of PHLF. Patients with PH experienced a higher incidence of complications and PHLF than patients without PH. On the Cox proportional hazards regression model, PH was verified as a risk factor of OS for BCLC stage 0/A and B patients. Patients without PH had significantly better long-term survival compared to patients with PH both in the total cohort and in cirrhosis subgroup.
CONCLUSION: Liver resection in HCC patients with PH showed a significantly increased postoperative complications and PHLF, and revealed a decreasing long-term survival than non-PH patients. Besides, tumor burden also played an important role in determining the OS. However, due to the improvement in surgical technique and perioperative management, surgery was feasible in carefully selected HCC patients with PH.

Entities:  

Keywords:  Hepatocellular carcinoma; complication; overall survival; portal hypertension; posthepatectomy liver failure

Mesh:

Year:  2018        PMID: 30572742     DOI: 10.1080/00365521.2018.1538386

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis.

Authors:  Jun Fu; Qinjunjie Chen; Yuyan Yu; Wuyi You; Zongren Ding; Yuzhen Gao; Haitao Li; Yongyi Zeng
Journal:  Cancer Med       Date:  2021-08-18       Impact factor: 4.452

2.  A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study.

Authors:  Jitao Wang; Zhanguo Zhang; Dong Shang; Yong Liao; Peng Yu; Jinling Li; Shubo Chen; Dengxiang Liu; Hongrui Miao; Shuang Li; Biao Zhang; Anliang Huang; Hao Liu; Yewei Zhang; Xiaolong Qi
Journal:  J Hepatocell Carcinoma       Date:  2022-08-27

3.  Development and Validation of a Nomogram Based on Noninvasive Liver Reserve and Fibrosis (PALBI and FIB-4) Model to Predict Posthepatectomy Liver Failure Grade B-C in Patients with Hepatocellular Carcinoma.

Authors:  Wenhui Zhong; Feng Zhang; Kaijun Huang; Yiping Zou; Yubin Liu
Journal:  J Oncol       Date:  2021-04-07       Impact factor: 4.375

4.  Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion.

Authors:  Wenhao Chen; Zijian Zhang; Xianrui Fang; Li Xiong; Yu Wen; Jiangjiao Zhou; Fanhua Kong; Heng Zou
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

5.  Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience.

Authors:  Yun Chen; Hanyu Qiu; Xiaomei Zhang
Journal:  BMC Surg       Date:  2019-12-12       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.